Regulation And Legal
MPS Pharmaa Reports Zero Investor Complaints Q1 2026
MPS Pharmaa Limited submits its mandatory quarterly investor complaint statement to BSE and ASE.
The filing confirms zero investor complaints pending, received, or resolved for the quarter ended June
